Samsung Biologics showcases its biopharmaceutical manufacturing technology at BPI 2026 in Boston
According to The Korea Times Business, Samsung Biologics showcased its biopharmaceutical manufacturing technologies at BioProcess International 2026 in Boston, presenting an integrated chemistry, manufacturing and controls strategy and the S-Tensify cell-culture platform, and highlighting its participation in BPI from Sept. 22–25 and its presence at Cell & Gene Therapy International. The event drew more than 3,000 biopharmaceutical professionals, and Samsung Biologics emphasized its capabilities across contract research, development and manufacturing. Abigail Garcia and James Choi were among the presenters, with Choi noting the company’s ongoing efforts to strengthen its global position in biopharmaceutical development.
Key facts
- 01BPI 2026 was held in Boston from Sept. 22–25, and Samsung Biologics had a booth and participated in multiple presentations.
- 02The event attracted more than 3,000 professionals from the biopharmaceutical sector.
- 03The S-Tensify cell-culture scale-up platform can increase cell density and deliver up to a twofold increase in yield while maintaining quality.
- 04Abigail Garcia and James Choi presented analyses and showcased the company’s capabilities and positioning in the global biopharmaceutical development market.
AI-generated from the sources below. Always check the originals.
How each country tells it
So far our sources show coverage from one country. Perspectives appear once we find reports from a second country.
Sources
Summaries are AI-generated from the linked sources and may contain errors; always check the originals. We summarise and link; we never republish articles. Photos come from openly licensed libraries, official publicity material and brand logos, credited to their sources. If you own an image and want it credited differently or removed, email info@coda.news and we will act promptly.
- Samsung Biologics highlights faster drug manufacturing timelines at BPI Boston · The Korea Times Business